267 related articles for article (PubMed ID: 27325686)
1. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme.
Cherry AE; Haas BR; Naydenov AV; Fung S; Xu C; Swinney K; Wagenbach M; Freeling J; Canton DA; Coy J; Horne EA; Rickman B; Vicente JJ; Scott JD; Ho RJ; Liggitt D; Wordeman L; Stella N
Mol Cancer Ther; 2016 Sep; 15(9):2018-29. PubMed ID: 27325686
[TBL] [Abstract][Full Text] [Related]
2. KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.
Ciesielski MJ; Bu Y; Munich SA; Teegarden P; Smolinski MP; Clements JL; Lau JYN; Hangauer DG; Fenstermaker RA
J Neurooncol; 2018 Dec; 140(3):519-527. PubMed ID: 30238350
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of (2E,5Z)-5-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl)imino) thiazolidin-4-one, a novel microtubule-depolymerizing agent, in U87MG human glioblastoma cells and corresponding mouse xenograft model.
Zhang Q; Liu X; Li X; Li C; Zhou H; Yan B
J Pharmacol Sci; 2013; 122(3):223-31. PubMed ID: 23877018
[TBL] [Abstract][Full Text] [Related]
4. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
[TBL] [Abstract][Full Text] [Related]
5. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
[TBL] [Abstract][Full Text] [Related]
6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
7. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
[TBL] [Abstract][Full Text] [Related]
8. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of Small Drugs in a Supramolecule Enhances Solubility, Stability, and Therapeutic Efficacy Against Glioblastoma Multiforme.
Tsiailanis AD; Renziehausen A; Karakurt S; Crook T; Syed N; Tzakos AG
Methods Mol Biol; 2021; 2207():175-186. PubMed ID: 33113136
[TBL] [Abstract][Full Text] [Related]
10. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
Katsetos CD; Draber P; Kavallaris M
Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.
Dorsey JF; Mintz A; Tian X; Dowling ML; Plastaras JP; Dicker DT; Kao GD; El-Deiry WS
Mol Cancer Ther; 2009 Dec; 8(12):3285-95. PubMed ID: 19996278
[TBL] [Abstract][Full Text] [Related]
13. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
[TBL] [Abstract][Full Text] [Related]
14. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
[TBL] [Abstract][Full Text] [Related]
15. Novel synthetic chalcones induces apoptosis in human glioblastoma cells.
Bittencourt LF; Oliveira KA; Cardoso CB; Lopes FG; Dal-Cim T; Chiaradia-Delatorre LD; Mascarello A; Maluf SW; Yunes RA; Garcez RC; Tasca CI; Nedel CB
Chem Biol Interact; 2016 May; 252():74-81. PubMed ID: 27012433
[TBL] [Abstract][Full Text] [Related]
16. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
17. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends.
Pagano A; Honoré S; Mohan R; Berges R; Akhmanova A; Braguer D
Biochem Pharmacol; 2012 Aug; 84(4):432-43. PubMed ID: 22634050
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice
Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
